Development and Commercialization Activities. Arcus shall use Commercially Reasonable Efforts to Develop and Commercialize Licensed Products. Arcus shall use Commercially Reasonable Efforts to manufacture or otherwise obtain supply of its requirements of packaged and labeled Licensed Products in connection with its Development and Commercialization obligations hereunder, in accordance with all Applicable Laws, GMP (as applicable) and this Agreement. For so long as Arcus is conducting Development activities under this Agreement, Arcus shall provide to WuXi, no later than on June 30 and December 31 of each calendar year, with written summaries of the Development activities it performed, or caused to be performed, in respect of Licensed Products since the preceding report (or, with respect to the first such report, since the Effective Date), and the future Development activities it *** CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. CONFIDENTIAL TREATMENT REQUESTED expects to initiate in respect of Licensed Products during the following six (6)-month period. Arcus agrees to consider any and all comments provided by WuXi in connection with such summaries in good faith.
Development and Commercialization Activities. The parties shall cooperate fully in connection with the development and commercialization of the Anti-IgE Product. Tanox shall assume primary responsibility in coordination with the Steering Committee (as defined in the D & L Agreement) for pursuing any additional development activities in the EA Countries which may be necessary or beneficial in connection with obtaining product registration and marketing approval in such countries. Ciba shall have the right to market and sell the Anti-IgE Product following marketing approval. Tanox shall have the right to supply product to the EA Countries at cost from its pilot facility in Houston, Texas, and/or from a facility owned and operated by the EA Company. To the extent Tanox is unable to supply all the product which may be required for the EA Countries, such product also may be purchased from Genentech or supplied by Ciba, as applicable.
Development and Commercialization Activities. Arcus shall use Commercially Reasonable Efforts to Develop and Commercialize Patented Products in the Field. Notwithstanding the foregoing, Arcus is obligated to file an IND in the United States on a Patented Product no later than [***] months from the Effective Date; provided that Stage 2 Technology Transfer, as defined in Section 3.3.1 below, is completed no later than [***] days following the Effective Date. The deadline for Arcus to file an IND in the United States on a Patented Product shall be extended by one (1) day for each day that Abmuno is late in completing Stage 2 Technology Transfer. Any delay or postponement in the filing of an IND in the United States on a Patented Product beyond the deadline for such filing will be subject to approval by Abmuno, which approval shall not be unreasonably withheld, conditioned or delayed.
Development and Commercialization Activities. Emergent and its Affiliates shall have the exclusive right to Exploit the Licensed Products in the Field in the Territory, and shall be solely responsible for any costs and expenses it incurs in connection with such Exploitation.
Development and Commercialization Activities. Myriad shall have the sole and exclusive right, but, except as expressly set forth in Section 2.5, not the obligation, to develop and commercialize the Licensed Compound and the Licensed Product on a worldwide basis. Myriad shall be solely responsible for all costs and expenses in connection with such development and commercialization activities; provided, however, that Licensor shall bear, and shall not be entitled to reimbursement for, any development or commercialization costs or expenses incurred by Licensor prior to the Effective Date with respect to the Licensed Compound, the Licensed Product, or the Manufacturing Processes. Except as provided in Section 2.8 hereof and elsewhere in this Agreement, or as otherwise agreed to in advance and in writing by Myriad, Myriad shall not be required to reimburse Licensor for any costs incurred by Licensor on or after the Effective Date of this Agreement.
Development and Commercialization Activities. ZYCOS shall have the sole right to Exploit the Products in the Field in the Territory. Except as otherwise expressly provided herein, ZYCOS shall be solely responsible for all costs and expenses in connection with such development and commercialization activities.
Development and Commercialization Activities. The purpose of this collaboration is to advance development of the Licensed Products as set forth in this Agreement and the Work Plan to completion of Proof of Principle Clinical Trials (the "Program"). The Program shall be conducted in accordance with this Agreement and with the plan and budget attached hereto as Exhibit 2.1, as amended from time-to-time in accordance herewith (the "Work Plan"). Corixa shall use all reasonable efforts to undertake and complete the Work Plan in an efficient manner and in accordance with high scientific standards.
Development and Commercialization Activities. Except for the activities assigned to Xenon under the Research Plan, as between the Parties, Genentech shall have the sole right and responsibility for, and control over, all research, Development and Commercialization of Collaboration Compounds, Licensed Products and Diagnostic Products in the Territory, at its sole cost. Genentech shall devote Diligent Efforts to the research, Development and Commercialization of Collaboration Compounds and Licensed Products, such Diligent Efforts which will specifically include the dedication of Diligent Efforts towards the Development and Commercialization of at least one (1) Licensed Product that contains a Collaboration Compound.
Development and Commercialization Activities. Subject to the cost-sharing and revenue sharing mechanics described below,
Development and Commercialization Activities
